Viking Therapeutics Statistics

Total Valuation

VKTX has a market cap or net worth of $5.74 billion. The enterprise value is $4.81 billion.

Market Cap	5.74B
Enterprise Value	4.81B

Important Dates

The last earnings date was Wednesday, October 23, 2024, after market close.

Earnings Date	Oct 23, 2024
Ex-Dividend Date	n/a

Share Statistics

VKTX has 111.44 million shares outstanding. The number of shares has increased by 19.97% in one year.

Current Share Class	111.44M
Shares Outstanding	111.44M
Shares Change (YoY)	+19.97%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	2.08%
Owned by Institutions (%)	74.94%
Float	105.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.30
P/TBV Ratio	6.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 36.47, with a Debt / Equity ratio of 0.00.

Current Ratio	36.47
Quick Ratio	36.23
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,395.50

Financial Efficiency

Return on equity (ROE) is -15.50% and return on invested capital (ROIC) is -13.06%.

Return on Equity (ROE)	-15.50%
Return on Assets (ROA)	-12.68%
Return on Capital (ROIC)	-13.06%
Revenue Per Employee	n/a
Profits Per Employee	-$3.67M
Employee Count	27
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +357.23% in the last 52 weeks. The beta is 0.99, so VKTX's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+357.23%
50-Day Moving Average	64.24
200-Day Moving Average	62.14
Relative Strength Index (RSI)	35.16
Average Volume (20 Days)	7,167,592

Short Selling Information

The latest short interest is 13.28 million, so 11.92% of the outstanding shares have been sold short.

Short Interest	13.28M
Short Previous Month	14.39M
Short % of Shares Out	11.92%
Short % of Float	12.59%
Short Ratio (days to cover)	3.89

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-133.97M
Pretax Income	-96.75M
Net Income	-99.15M
EBITDA	n/a
EBIT	-133.97M
Earnings Per Share (EPS)	-$0.93

Full Income Statement

Balance Sheet

The company has $930.44 million in cash and $1.24 million in debt, giving a net cash position of $929.21 million or $8.34 per share.

Cash & Cash Equivalents	930.44M
Total Debt	1.24M
Net Cash	929.21M
Net Cash Per Share	$8.34
Equity (Book Value)	911.45M
Book Value Per Share	8.18
Working Capital	910.96M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-74.25M
Capital Expenditures	n/a
Free Cash Flow	-74.25M
FCF Per Share	-$0.67

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.97%
Shareholder Yield	-19.97%
Earnings Yield	-1.73%
FCF Yield	-1.29%

Dividend Details

Analyst Forecast

The average price target for VKTX is $109.80, which is 113.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$109.80
Price Target Difference	113.08%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2